Crawford Drug, LLC
Outcome
Crawford Drug self-disclosed to OIG and settled for $78,248.25 for submitting prescription drug claims for medications that were never dispensed to patients.
Details
Crawford Drug, LLC (Dorchester, MA) — Billing for Prescription Drugs Not Dispensed
Outcome: Self-disclosed to OIG and settled for $78,248.25 for submitting claims for prescription drugs that were never dispensed to patients.
Crawford Drug, LLC, a pharmacy in Dorchester, Massachusetts, self-disclosed to HHS-OIG that it had submitted claims to federal healthcare programs for prescription drugs that were not actually dispensed to patients. The pharmacy then agreed to a settlement to resolve the Civil Monetary Penalties Law violation.
The voluntary self-disclosure reflects a functioning compliance program that identified the billing discrepancy and reported it proactively. The $78,248.25 settlement on August 22, 2025 represents a relatively modest penalty commensurate with the self-disclosure credit and the likely limited scope of the undispensed drug claims.
How Crucible Prevents This
Crucible's dispense-to-bill reconciliation controls would flag claims submitted without corresponding dispense records; an automated matching of point-of-sale dispense logs against claim submissions would surface undispensed medication billing within each billing cycle.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works